Miotolan

Miotolan, also known by its scientific name Furazabol, is a synthetic, orally active anabolic-androgenic steroid (AAS). It was originally developed in Japan and marketed under the brand names Frazalon and Miotolan. Structurally, it is a derivative of dihydrotestosterone (DHT) and is closely related to another well-known steroid, stanozolol.

Side Effects and Benefits

Benefits:

• As an anabolic steroid, its primary benefit is the promotion of muscle growth and strength.

• In a medical context, it was once used as a lipid-lowering agent.

Side Effects:

• Hepatotoxicity: Like other 17α-alkylated oral steroids, Miotolan carries a risk of liver damage.

• Androgenic effects: Despite a favorable anabolic-to-androgenic ratio, chronic use can lead to virilization in women (development of male characteristics like irregular menstruation, breast atrophy, and clitoromegaly) and other androgen-related side effects in both men and women, such as acne and male-pattern baldness.

• Cardiovascular and other health risks: Prolonged use can lead to a range of health issues, including cardiovascular disease, prostatic hypertrophy in men, and psychiatric changes.

Pros and Cons

Pros:

• High anabolic-to-androgenic ratio, meaning it is more effective at building muscle with less of the masculinizing side effects compared to some other steroids.

• Orally active, which is a convenient route of administration.

Cons:

• Hepatotoxicity: The primary concern with Miotolan is the risk of liver damage due to its 17α-alkylation.

• Illegal use: Its use for athletic performance enhancement is banned by major sports organizations, and it is a controlled substance in many countries.

• Side effects: It still carries the risk of a variety of side effects, including hormonal, cardiovascular, and psychological issues.

Dosage and Frequency

Information on specific dosages and frequencies for Miotolan is not readily available through official medical sources, as it is no longer widely prescribed. The use of such substances outside of medical supervision is dangerous and illegal. Dosage information often circulated in non-medical communities is anecdotal and can be highly risky.

Half-Life and Detection Time

• Half-life: The elimination half-life of Miotolan (Furazabol) is approximately 4 hours. This refers to the time it takes for half of the drug to be cleared from the body.

• Detection time: The detection time, or how long it can be detected on a drug test, is much longer than its half-life. While precise data is limited, anabolic steroids with similar short half-lives can often be detected in urine for several weeks, and in hair for much longer, depending on various factors such as dosage, duration of use, individual metabolism, and the sensitivity of the testing method.

Sterogenic, Progestogenic, and Prolactin Effects

• Sterogenic: As an anabolic-androgenic steroid, Miotolan is a synthetic steroid. It exerts its effects by binding to and activating androgen receptors in the body's cells, leading to increased protein synthesis and muscle growth.

• Progestogenic: There is no widely available information to suggest that Miotolan has significant progestogenic activity.

• Prolactin: There is also no specific information linking Miotolan to direct effects on prolactin levels. However, some anabolic steroids can indirectly influence the endocrine system, which may have downstream effects. The interaction between steroids and the endocrine system is complex.

Anabolic-Androgenic Ratio

The anabolic-androgenic ratio (AAR) of Miotolan is generally considered to be high. It is reported to be around 10:1 when compared to testosterone, which has a ratio of 1:1. This means it is considered to be ten times more anabolic (muscle-building) than it is androgenic (masculinizing). However, it's important to note that these ratios are often based on older studies and can be misleading, as all anabolic-androgenic steroids still carry a risk of androgenic side effects, especially with high doses and long-term use.